CClinicalTrials.gg
CompletedNCT05041075Updated Jun 15, 2025

Effect of Weighted Blankets on Anxiety for Pediatric Oncology Patients

An interventional study of Weighted Blanket in Pediatric Cancer, sponsored by University of Colorado, Denver. Completed at 1 site in United States. Open to participants aged 4 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-06-15.

Sponsored by University of Colorado, Denver · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
4 Years to 17 Years
Sex
All
01

Study summary

The use of weighted blankets has been studied in the adult population but there is a lack of evidence to determine their benefit among a pediatric population, specifically oncology pediatric patients. Pediatric oncology patients routinely experience anxiety during therapy and as cure rates increase, attention has progressively turned to treating psychosocial aspects of care.

Read the detailed description

A randomized 2x2 cross-over design will be utilized for this study. The study team will randomize participants to one of two sequences: 1) weighted blanket first then usual care or 2) usual care first then weighted blanket. The cross-over design allows the researchers to compare both within and between group differences. The advantages of the cross-over design allow minimize potential confounding bias as patients will serve as their own controls as well as potential for adequate power with smaller patient enrollment. As this study is conducted during chemotherapy treatments, the 30-day period in between patient treatments will be considered the washout period. This timeframe between chemotherapy infusions was chosen to try to capture patients in a similar state of baseline anxiety. This helps to provide adjustments to variability but should not limit accrual based on the number of patients that get chemotherapy within a 30-day period.

02

Conditions studied

  • Pediatric Cancer

Browse trials for

03

In context

Body Weight

1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.

This study's enrollment of 26 is below the median of 64 across 947 interventional studies indexed under Body Weight.

Browse Body Weight studies →

Lead sponsor

University of Colorado, Denver is the lead sponsor of 1,499 studies on the registry; 315 are open to participants now.

Of its 139 completed or terminated interventional studies of FDA-regulated products, 89 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Newly diagnosed pediatric oncology patients between the ages of 4 and 17 receiving outpatient chemotherapy infusions in one of the two designated out patient locations (Anschutz Campus and Colorado Springs Hospital)
  • Patients who have a "liquid tumor" (leukemia or lymphoma), "solid tumor", or a neuro-oncologic diagnosis
  • Patients who can complete the CAM-S and CAM-T as proven by seriation screening.
  • Patients who are great than 13.5kg in weight, due to weighted blanket size options
  • Patients whose second and third outpatient chemotherapy occur within 30 days of each other.
  • English and Spanish speaking

Exclusion criteria

Exclusion Criteria:

  • Patients who are younger than 4 years of age, or older than 17 years of age
  • Relapsed patients
  • Patients who are undergoing bone marrow transplant or had a previous bone marrow transplant
  • Patients receiving chemotherapy infusions at North Campus and South Campus locations
  • Patients in the inpatient setting
  • Patients who utilize a weighted blanket at home currently or previously
  • Patients who fail seriation screening during enrollment
  • Patients who start initial chemotherapy infusions in the outpatient setting
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
26 participants (actual)

Study arms

  • Active comparator
    WB:UC

    Weighted Blanket 2nd infusion Usual Care 3rd infusion

    Device: Weighted Blanket

  • Active comparator
    UC:WB

    Usual Care 2nd infusion Weighted Blanket 3rd infusion

    Device: Weighted Blanket

Interventions

  • DeviceWeighted Blanket

    Weighted blankets provide Deep Pressure Stimulation (DPS) or Deep Touch Pressure (DTP) which has advantages in both physical and psychological domains.

06

What researchers measure

Primary outcomes

  1. Children's Anxiety Meter-State (CAM-S) assessment

    The CAM-S is completed by showing the child a picture of a mercury thermometer and asking the child to "Pretend that all of your worried or nervous feelings are in the very bottom down here (point to scale). If you are a little bit worried or nervous, the feelings might come up just a little bit (move finger up). If you are very, very worried, or nervous, the feelings might come up just a little bit (move finger up to the top). Put a line showing how much worry or nervousness you feel right now." This scale is from measured from 1-10. Higher values indicate higher anxiety. The CAM-S will be administered during the following times: prior to infusion start, thirty minutes into the treatment or end of the treatment if \<30 minutes and end of the treatment (see Figure 1).

    Time frame: 12 months

Secondary outcomes

  1. Pediatric Quality of Life Inventory Generic Core Scales (Peds QL 4.0)

    The Peds QL 4.0 is a 23-item questionnaire and is broken up into four sections: physical functioning (8 items), emotional functioning (5 items), social functioning (5 items), and school functioning (5 items). These questions are aimed to measure health-related quality of life in children and adolescents who are healthy and those with acute or chronic health conditions (Varni, Burwinkle, Seid \& Skarr, 2003). We will utilize the parent-proxy questionnaires with responses measured on a 5-point response scale: 0 = never a problem; 1= almost never a problem; 2 = sometimes a problem; 3 = often a problem; 4 = almost always a problem. The scale is recoded and summarized to have a score ranging from 0 to 100 where higher values indicate higher quality of life.

    Time frame: 12 months

Other outcomes

  1. Weighted Blanket Use

    Prior to discharge, a trained infusion nurse or a member of the weighed blanket research team will ask participants/families to classify if the participant used the blanket 0-20%, 20-40%, 40-60%, 60-80%, or 80-100% of their total infusion time.

    Time frame: 12 months

07

Study locations

1 site
  • Children's Hospital Colorado
    Aurora, Colorado 80045, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05041075
Lead sponsor
University of Colorado, Denver
Collaborators
Children's Hospital Colorado
Responsible party
Sponsor
First posted
Sep 10, 2021
Start date
Jan 10, 2022
Primary completion
Jul 25, 2023
Completion
Jul 25, 2023
Last update
Jun 15, 2025

Study contacts

Jennifer Olson
principal investigator · Children's Hospital Colorado

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion